Barcelona

• A Study of the Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination with Venetoclax in AML Ended recruitment
  2024-516294-78-00 4 2022-06-17 Acute Myeloid Leukemia (AML)
• A study to test whether different combinations of BI 765063, ezabenlimab, chemotherapy, cetuximab, and BI 836880 help people with head and n … Ended recruitment
  2024-512799-36-00 3 2022-06-16 head and neck squamous cell carcinoma (HNSCC)
• A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosus (EMERALD) Ended recruitment
  2023-505635-13-00 5 2022-06-10 Systemic lupus erythematosus
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cho … Ended recruitment
  2023-505764-11-00 4 2022-06-10 Pruritus associated with Primary Sclerosing Cholangitis (PSC)
• A Global Study to Assess the Effects of Durvalumab with Oleclumab or Durvalumab with Monalizumab Following Concurrent Chemoradiation in Pati … Ended recruitment
  2023-503999-24-00 5 2022-06-01 Patients With Locally Advanced (Stage III), Unresectable Non-small Cel
• Study to Evaluate how effective and safe the investigationall product, Mitapivat, is when administred to Pediatric Subjects With Pyruvate Ki … Ended recruitment
  2024-515024-37-00 5 2022-05-27 Pyruvate Kinase Deficiency
• A phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine … Ended recruitment
  2024-516315-24-00 5 2022-05-27 myopia
• This study is to understand how well an investigational drug (called Napabucasin) works when given in combination with chemotherapy treatmen … Ended recruitment
  2024-518205-17-00 10 2022-05-27 Histologically or cytologically confirmed advanced pancreatic adenocar
• A research study to evaluate the activity of Sotorasib for the treatment of patients with non-operable non-small cell lung cancer with a KRA … Ended recruitment
  2024-511268-10-00 4 2022-05-25 Unresectable stage III (IIIA-N2, IIIB, IIIC) KRAS p.G12C non-small cel
• A late stage clinical trial to investigate the efficacy and safety of Osimertinib versus Placebo in patients with stage IA2-IA3 non-small ce … Ended recruitment
  2023-509943-28-00 5 2022-05-18 Stage IA2-IA3 non-small cell lung carcinoma, with EGFR mutation type (
• A Placebo-Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease … Ended recruitment
  2023-507795-51-00 5 2022-05-17 atherosclerotic heart and blood vessel disease (the narrowing of arter
• A Study to Evaluate Long-Term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients with Neovascular Age-Related … Ended recruitment
  2023-507131-38-00 5 2022-05-16 Neovascular Age-Related Macular Degeneration (nAMD)
• A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblasto … Ended recruitment
  2023-506719-17-00 3 2022-05-10 Glioblastoma
• Genetic vaccine for the treatment of microsatellite unstable solid tumors Ended recruitment
  2024-514723-42-00 9 2022-05-05 Locally advanced unresectable or metastatic, microsatellite instabilit
• A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate Risk Myel … Ended recruitment
  2023-507469-24-00 4 2022-04-30 Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodyspl
• A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants with Amyloid Light Chain (AL) Amyloidosis Ended recruitment
  2023-507069-25-00 4 2022-04-29 Amyloid Light Chain Amyloidosis
• A Phase 3 Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant Ended recruitment
  2023-508897-27-00 5 2022-04-28 Multiple Myeloma
• A study in patients with skin cancer Ended recruitment
  2024-516914-39-00 5 2022-04-27 Metastatic or unresectable melanoma
• New Clinical End-points in patients with primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients Ended recruitment
  2023-510054-16-00 4 2022-04-26 Primary Sjogren's syndrome
• This study is to understand how well an investigational drug (called Napabucasin) works when given in combination with a chemotherapy treatm … Ended recruitment
  2024-518204-50-00 5 2022-04-25 Histologically confirmed adenocarcinoma of the colon or rectum that is
• DISCUS: A Randomised Phase II Study Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothel … Ended recruitment
  2024-518244-20-01 4 2022-04-25 Urothelial Carcinoma
• A study to evaluate KER-050 as a monotherapy or in combination with Ruxolitinib in Myelofibrosis. Ended recruitment
  2023-507468-38-00 4 2022-04-22 Myelofibrosis
• A Study to Evaluate Overall Health, Physical Activity and Joint Outcomes, in Participants with Severe or Moderate Hemophilia A without FVIII … Ended recruitment
  2023-505747-40-00 6 2022-04-20 Severe or Moderate Hemophilia A
• Open-Label and Long-term Extension Study with Dersimelagon (MT-7117) in Subjects with EPP or XLP Ended recruitment
  2024-514466-38-00 5 2022-04-19 Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Showing 2,113–2,136 of 3,391 trials